Note: Any up-dates are to be completed in different color ink.

The student is expected to document all meds the client is currently receiving.
MEDICATION NAME DOSE, ROUTE, EFFECTS PREGANCY
GENERIC/TRADE INDICATION/ ACTION TIMES FOOD/DRUG INTERACTIONS SIDE EFFECTS FETUS AND/OR NURSING CONSIDERATIONS
CLASSIFICATION DOSGE/RANGE NEONATE
(PHARM) AND (include therapeutic
PREGNANCY dose calculation)
CATEGORY
Management of PO Adult-10- Additive hypotension Gynecomastia, Contraindicated for Monitor blood pressure and pulse
Nifedpine hypertension, (extended- 30mg 3 times may occur when used hyperglycemia, anemia, pregnancy, before therapy, during dose titration,
(Procardia, release only, Angina daily (not to concurrenly with leukopenia, lactation, children and periodically during therapy.
Procardia XL, pectoris, vasopastic, exceed fentanyl, other thrombocytopenia, weight (safety not Monitor ECG periodically prolonged
Adalat, adalt CC, prinzmetal’s angina. 180mg/day), or antihypertensives, nirates, gain, joint stiffness, muscle established).Patient therapy. Monitor intake and output
Adalal PA, Adala Unlabeled uses- Prevention 10-20mg twice acute ingestion of cramps, paresthesia, tremor, s with history of ratios and daily weight. Assess for
XL, Afeditab CR, of migraine headache. daily as PA form, alcohol, or quinidine. Steven-Johsonson serious ventricular signs of CHF (peripheral edema,
Apo-Nifed, Nifedical Management of CHF or or 30-90mg once Antihypertensive effects Syndrome, gingival arrhythmias, rales/crackles, dyspnea, weight gain,
XL, Novo-Nifedin, cardiomyopathy. Inhibits daily as may decrease by hyperplasia. Headache, caution in use for jugular venous distention). Assess
Nu-Nifed). calcium transport into sustained-release concurrent use of abnormal dreams anxiety, severe hepatic fall risk and institute fall prevention
myocardial and vascular (CC<XL) fom NSAIDs. May increase confusion, dizziness, impairment strategies. Patients receiving digoxin
Antianginals, anti- smooth muscle, cells, (not to exceed 90- serum levels and risk of drowsiness, jitteriness, (decrease dose concurrently with Nifedipine should
hypertiensives resulting in inhibition of 120mg/day). toxicity form digoxin, nervousness, psychiatric recommended), have routine tests of serum digoxin
excitation-contraction disopyramide, or disturbances, weakness, hypersensitivity levels and be monitored for signs and
coupling and subsequent phenytoin may result in blurred vision, disturbed and sick sinus symptoms of digoxin toxicity.
Preg. Cat. C contraction. Systemic bradycardia, conduction equilibrium, epistaxis, and syndrome. Assess location, duration, intensity,
vasodilatation, resulting in defects or CHF. tinnitus. Cough, dyspnea, and precipitating factors of patient’s
Davis Drug Guide decrease blood pressure. Cimetidine and shortness ofr breath, anginal pain. Total serum calcium
for Ns. Page 884-886 Coronary vasodilation, propranolol may decrease arrhythmias, CHF, concentrations ar no affected by
resulting in decreased metabolismand increase peripheral edema, calcium channel blockers. Monitor
Pharmacology for frequency and severity of risk of toxicity. May bradycardia, chest pain, renal and hepatic functions
nursing Care page attacks of angina. decrease metabolism of abnormal liver function periodically during long-term
477 and increase risk of toxity studies, anorexia, dyspepsia, therapy. Several days of therapy may
form cyclosporine, nausea, vomiting, dysuria, cause increase in heptic enzymes,
prazosin, quinidine, or nocturia, polyuria, sexual which return tonormal upon
carbamazepine. dysfunction, urinary discontinuation of therapy.
Grapefruit and grapefruit frequency, flushing, Administer without regard to meals
juice increase serum dermatitis, erythema and with meals if GI irritation
levels and effect. mulifome, increase becomes a problem.
Sublingual use is not sweating, photosensitivity,
recommended due to pruritus/urticaria, rash.
serious adverse dug
reactions.

PHARM